Inherited retinal disease

Optos will have a strong presence on the Australian ophthalmic events circuit in 2025, providing a key opportunity for eyecare...

Four eye research projects have secured more than $8 million in funding in the 2025 National Health and Medical Research...

Outcomes from the bionic eye trial have demonstrated the device’s long-term durability and stability in the retina. The detailed outcomes...

From the beginning of the genetic revolution when the double helix DNA model was first described in the 1950s, to...

The Centre for Eye Research Australia (CERA) has established Cerulea Clinical Trials, a new specialist ophthalmic clinical trial facility in...

A landmark clinical trial has demonstrated that a CRISPR-based therapy is safe and effective in the treatment of inherited retinal...

At the completion of this article, the reader should be able to improve their management of people with low vision,...

At the completion of this article, optometrists and other readers should be able to improve their management of people with...

  At the completion of this CPD activity, optometrists will understand the clinical utility of optical coherence tomography angiography (OCT-A),...

Non-profit organisation Eyes for Life Canberra (EFLC) is hosting a professional development event for optometrists on Tuesday 24 October, featuring...